Next Quarterly Earnings
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Nuvation Bio is an innovative US-based biopharmaceutical company specializing in the development of novel cancer therapies. Through cutting-edge research, the company focuses on creating transformative treatment methods for patients suffering from severe forms of cancer.
Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Nuvation Bio is scheduled to report its next quarterly earnings on 11/11/2026. Pre-market — typically before 3:30 p.m. German time (before the US open at 9:30 a.m. New York time).
Nuvation Bio last reported quarterly earnings on 8/6/2026 (Q2 2026). Earnings per share (EPS) came in at -0.18 USD.
Nuvation Bio has beaten analyst EPS estimates in 3 of its last 5 evaluated quarters (beat rate: 60%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 5 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.